Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ6K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467.00 delivery order to Amerisourcebergen Drug Corp on January 14, 2026, for the supply of Skyrizi 360 mg/2.4 ml on-body 2.4 ml injections. This firm fixed-price contract, which carries an ultimate completion date of February 5, 2026, represents a task order under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania. Skyrizi is a biologic medication used primarily for the treatment of plaque psoriasis and other inflammatory conditions, reflecting the range of specialty pharmaceuticals that Amerisourcebergen supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal agencies including the Department of Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent company, Cencora, Inc., holds the primary $999,999,999.00 IDC with DLA Troop Support Medical through December 2031, positioning the organization as a critical vendor for federal pharmaceutical procurement across multiple therapeutic domains including specialty medications, vaccines, and medical supplies.
Quick answers
Who was awarded contract SPE2DR26FCZ6K?
SPE2DR26FCZ6K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FCZ6K worth?
The government has obligated $12,467 on SPE2DR26FCZ6K.
Is contract SPE2DR26FCZ6K an order under another contract?
Yes. SPE2DR26FCZ6K is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ6K competed?
The extent of competition for SPE2DR26FCZ6K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award